CAMP Insider Trading Activity and SEC Form 4 Filings
CAMP insider trading summary
Over the past 12 months, insiders at Camp4 Therapeutics Corp (CAMP) reported 6 sales worth $2.5M by 2 insiders and 5 open-market purchases worth $99K by 4 insiders on SEC Form 4. Net insider selling was $2.4M.
Latest CAMP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Kelly Gold | Chief Financial Officer | Buy | $40K (10,000 @ $3.96) |
| Aug 27, 2026 | Andrew J. Schwab | Insider | Sell | $1.6M (400,000 @ $4.04) |
| Aug 24, 2026 | Andrew J. Schwab | Insider | Sell | $45 (10 @ $4.50) |
| Aug 21, 2026 | Andrew J. Schwab | Insider | Sell | $144K (32,018 @ $4.50) |
| Aug 20, 2026 | Andrew J. Schwab | Insider | Sell | $521K (114,700 @ $4.54) |
| Aug 19, 2026 | Daniel Tardiff | Chief Scientific Officer | Sell | $8K (1,738 @ $4.76) |
| Aug 19, 2026 | Andrew J. Schwab | Insider | Sell | $215K (45,147 @ $4.76) |
| Aug 3, 2026 | Yuri Maricich | Chief Medical Officer | Buy | $11K (6,551 @ $1.65) |
| Aug 3, 2026 | Kelly Gold | Chief Financial Officer | Buy | $11K (6,551 @ $1.65) |
| Aug 3, 2026 | Josh Mandel-Brehm | Chief Executive Officer | Buy | $11K (6,551 @ $1.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.